Published in BMJ on March 28, 1992
Use of pulsed-field gel electrophoresis for epidemiological study of Bordetella pertussis in a whooping cough outbreak. J Clin Microbiol (1994) 4.13
Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol (2001) 2.02
Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg Infect Dis (2002) 1.58
Analysis of Bordetella pertussis isolates from an epidemic by pulsed-field gel electrophoresis. J Clin Microbiol (1995) 1.15
Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains. J Clin Microbiol (2003) 0.98
Application of pulsed field gel electrophoresis to the 1993 epidemic of whooping cough in the UK. Epidemiol Infect (1995) 0.94
Reproducibility of Bordetella pertussis genomic DNA fragments generated by XbaI restriction and resolved by pulsed-field gel electrophoresis. J Clin Microbiol (2002) 0.91
Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use. J Clin Microbiol (2011) 0.82
Clinical applications of molecular biology to diagnostic microbiology. J Clin Pathol (1992) 0.76
Infectious diseases. Postgrad Med J (1994) 0.75
Is Bordetella pertussis clonal? BMJ (1992) 0.75
Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis. Cell (1984) 31.52
Purification, specific fragmentation, and separation of large DNA molecules. Methods Enzymol (1987) 7.40
Restriction endonucleases for pulsed field mapping of bacterial genomes. Nucleic Acids Res (1987) 7.03
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
Technical problems in the laboratory diagnosis and prevention of whooping-cough. Lab Pract (1970) 3.05
Pulsed-field gel electrophoresis of very large DNA molecules. Annu Rev Biophys Biophys Chem (1988) 2.47
Developments in pertussis immunisation in Japan. Lancet (1990) 1.09
Recognising whooping cough. Br Med J (Clin Res Ed) (1986) 0.98
Pertussis and pertussis vaccine in the developing world. Tokai J Exp Clin Med (1988) 0.91
An association between sudden infant death syndrome (SIDS) and Helicobacter pylori infection. Arch Dis Child (2000) 8.02
Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. Br Med J (Clin Res Ed) (1985) 2.74
Toxoid vaccine for pertussis. Lancet (1997) 2.43
Application of polymerase chain reaction to fingerprinting Aspergillus fumigatus by random amplification of polymorphic DNA. J Clin Microbiol (1993) 2.34
Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol Infect (1999) 2.24
Application of the polymerase chain reaction to the diagnosis of candidosis by amplification of an HSP 90 gene fragment. J Med Microbiol (1993) 2.02
Immunoblot analysis of the serological response in systemic candidosis. Lancet (1984) 1.90
Immunoblot fingerprinting Aspergillus fumigatus. J Immunol Methods (1989) 1.77
Genetic relatedness of Bordetella species as determined by macrorestriction digests resolved by pulsed-field gel electrophoresis. Int J Syst Bacteriol (1993) 1.76
Immunoblotting to demonstrate antigenic and immunogenic differences among nine standard strains of Clostridium difficile. J Clin Microbiol (1986) 1.73
Restriction endonuclease analysis of Aspergillus fumigatus DNA. J Clin Pathol (1992) 1.65
Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin Microbiol (1987) 1.58
Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology (1991) 1.49
The abortion issue: a "battle worth fighting". Tex Med (1992) 1.38
Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur J Clin Microbiol Infect Dis (2000) 1.37
Evaluation of the Ramco latex agglutination test in the early diagnosis of systemic candidiasis. Eur J Clin Microbiol (1985) 1.20
Control of an outbreak of systemic Candida albicans. Br Med J (Clin Res Ed) (1985) 1.19
Invasive aspergillosis: clusters and sources? J Med Vet Mycol (1994) 1.15
Immunoblot analysis of serological responses in invasive aspergillosis. J Clin Pathol (1985) 1.12
Use of immunoblotting to identify antigenic differences between the yeast and mycelial phases of Candida albicans. J Clin Pathol (1985) 1.10
"Pseudoclusters" and typing by random amplification of polymorphic DNA of Aspergillus fumigatus. J Clin Pathol (1995) 1.10
Role of immunoblotting in the diagnosis of culture negative and enterococcal endocarditis. J Clin Pathol (1987) 1.09
Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections. Infect Immun (2000) 1.07
Immunodiagnosis of invasive fungal infections. J Med Vet Mycol (1994) 1.01
Four outbreaks of nosocomial systemic candidiasis. Epidemiol Infect (1987) 1.01
Immunoblot fingerprinting of coagulase negative staphylococci. J Clin Pathol (1988) 1.01
Semiquantitative polymerase chain reaction enzyme immunoassay for diagnosis of disseminated candidiasis. Eur J Clin Microbiol Infect Dis (1997) 1.01
Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit. BMJ (1989) 1.00
A comparison of the DNA fragment patterns of the mouse-virulent challenge strains and clinical isolates of Bordetella pertussis. J Infect (1993) 1.00
A comparison of immunoblot and DNA restriction patterns in characterising methicillin-resistant isolates of Staphylococcus aureus. J Med Microbiol (1989) 0.99
An epidemiological study of blood culture isolates of coagulase-negative staphylococci demonstrating hospital-acquired infection. J Clin Microbiol (1997) 0.99
Hospital outbreaks with yeasts. J Hosp Infect (1991) 0.99
Stress proteins in fungal diseases. Med Mycol (1998) 0.97
Clamped homogeneous electric field gel electrophoresis typing of Torulopsis glabrata isolates causing nosocomial infections. J Clin Microbiol (1992) 0.97
Immunoblot analysis: a new method for fingerprinting hospital pathogens. J Immunol Methods (1987) 0.97
Candida and hands. J Hosp Infect (1986) 0.94
Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus. Clin Infect Dis (1997) 0.94
Application of pulsed field gel electrophoresis to the 1993 epidemic of whooping cough in the UK. Epidemiol Infect (1995) 0.94
Heat shock protein 88 and Aspergillus infection. J Clin Microbiol (1991) 0.93
The application of epitope mapping in the development of a new serological test for systemic candidosis. J Immunol Methods (1991) 0.93
Mechanisms of anaesthesia. Lancet (1981) 0.92
Identification of an immunodominant drug efflux pump in Burkholderia cepacia. J Antimicrob Chemother (2002) 0.91
Immunoblot analysis of the serological response in invasive Trichosporon beigelii and Blastoschizomyces capitatus infections. J Clin Microbiol (1986) 0.91
Karyotyping of fluconazole-resistant yeasts with phenotype reported as Candida krusei or Candida inconspicua. Int J Syst Bacteriol (1996) 0.91
Kitchens as a source of Aspergillus niger infection. J Hosp Infect (1996) 0.90
Fingerprinting methicillin-resistant Staphylococcus aureus by the immunoblot technique. J Med Microbiol (1988) 0.88
Characterisation and cellular localisation of the immunodominant 47-Kda antigen of Candida albicans. J Med Microbiol (1988) 0.88
Cluster of clinical isolates of epidemic methicillin-resistant Staphylococcus aureus (EMRSA) with a negative deoxyribonuclease (DNase) test-implications for laboratory diagnosis and infection control. J Hosp Infect (2002) 0.85
Immunoblot analysis of serological response to Pseudomonas aeruginosa septicaemia in man. J Clin Pathol (1986) 0.84
The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections. Med Mycol (2000) 0.84
Defining antibody targets in Streptococcus oralis infection. Infect Immun (1996) 0.82
Transient abrogation of immunosuppression in a patient with chronic mucocutaneous candidiasis following vaccination with Candida albicans. J Infect (1987) 0.81
Cloning and sequencing the endocarditis immunodominant antigen of Streptococcus sobrinus strain MUCOB 263. J Med Microbiol (1994) 0.80
Epitope mapping Candida albicans proteinase (SAP 2). FEMS Immunol Med Microbiol (1997) 0.80
Characterization of outbreak and vaccine strains of Bordetella pertussis--Quebec. Can Commun Dis Rep (1993) 0.80
The Bpel locus encodes type III secretion machinery in Bordetella pertussis. Microb Pathog (1999) 0.80
PCR fingerprinting microbes by random amplification of polymorphic DNA. J Med Microbiol (1993) 0.80
Defining potential targets for immunotherapy in Burkholderia cepacia infection. FEMS Immunol Med Microbiol (1995) 0.79
Epitope mapping human heat shock protein 90 with sera from infected patients. FEMS Immunol Med Microbiol (1994) 0.79
Survival after rupture of the oesophagus and subsequent candidal endocarditis: use of new serological methods in management. Eur Heart J (1989) 0.79
Recurrent Escherichia coli bacteraemia in a patient with chronic renal failure. Nephrol Dial Transplant (2001) 0.78
A polymerase chain reaction enzyme immunoassay for diagnosing infection caused by Aspergillus fumigatus. J Clin Pathol (1999) 0.78
Inhaled CO2 and progressive hypoxia: ventilatory response in a yearling and a newborn harbor seal. Life Sci II (1973) 0.78
Comparison of three typing methods for clinical and environmental isolates of Aspergillus fumigatus. J Clin Microbiol (1995) 0.77
Immunoblotting and culture positive endocarditis. J Clin Pathol (1991) 0.77
A PCR-based approach to sequence the Candida tropicalis HSP90 gene. FEMS Immunol Med Microbiol (2000) 0.77
Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting. J Infect (2000) 0.77
Quantification of Escherichia coli genomic DNA contamination in recombinant protein preparations by polymerase chain reaction and affinity-based collection. Anal Biochem (2001) 0.77
Characterization of the antibody response in Corynebacterium jeikeium septicaemias. Epidemiol Infect (1990) 0.77
Clinical applications of molecular biology to diagnostic microbiology. J Clin Pathol (1992) 0.76
Intervertebral infection due to Candida albicans in an intravenous heroin abuser. Ann Rheum Dis (1988) 0.76
The effect of an accelerated immunisation schedule on pertussis in England and Wales. Commun Dis Rep CDR Rev (1996) 0.76
Transmission of pertussis: do adults have an important role? Lancet (1996) 0.76
The renaissance of antibody therapy. J Antimicrob Chemother (1998) 0.76
Components of acellular pertussis vaccines. Lancet (1996) 0.75
Chylopericardium, chylothorax, and hypobetalipoproteinaemia. Br Med J (Clin Res Ed) (1986) 0.75
Pulmonary problems of the immunocompromised patient. Br Med J (Clin Res Ed) (1981) 0.75
Immunological and bacteriological distinction between parapertussis and pertussis. Lancet (1995) 0.75
Ciprofloxacin-resistant Staphylococcus epidermidis and hands. Lancet (1997) 0.75
Human recombinant antibody to HSP90: a natural partner in combination therapy. Curr Mol Med (2005) 0.75
Acellular pertussis vaccines: progress but déjà vu. Lancet (1998) 0.75
Sensitive and universal method for microbial DNA extraction from blood products. J Clin Pathol (1996) 0.75
Is it time to stop searching for MRSA? Constant vigilance is needed to halt the emergence of resistance to vancomycin. BMJ (1997) 0.75